Newsfiscal.ai
BioVie Invited to Present Data on Bezisterim at NIH's RECOVER-TLC Workshop
· Published
Article summary
BioVie Inc. has been invited to present clinical data on its investigational therapy, bezisterim, at the 2026 RECOVER–Treating Long COVID (RECOVER-TLC) Hybrid Workshop.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…